Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
CONCLUSIONS: SST or CXCR4 expression in PAC is clearly of no therapeutic relevance. However, indirect targeting of these tumours via SST3, SST5, or CXCR4 on tumour microvessels may represent a promising additional therapeutic strategy.
PMID: 31451931 [PubMed - as supplied by publisher]
Source: Clin Med Res - Category: Research Authors: Kajtazi Y, Kaemmerer D, Sänger J, Schulz S, Lupp A Tags: J Cancer Res Clin Oncol Source Type: research
More News: Adenocarcinoma | Brain | Cancer | Cancer & Oncology | Neurology | Pancreas | Pancreatic Cancer | Research